Biohaven Pharmaceutical Hold
13F holders, Q3 2025 (September 30)2holders
0new positions
0sold out
$15.01avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Biohaven Pharmaceutical Hold in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Knoll Capital Management, LLC ($13.4M) and FNY Investment Advisers, LLC ($34K).
- Company
- Biohaven Pharmaceutical Hold
- CUSIP
- G11196105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Knoll Capital Management, LLC | 7.20% | No change | 895,269 | $13.4M |
| FNY Investment Advisers, LLC | 0.01% | No change | 2,300 | $34K |
"% of holder's portfolio" is BIOHAVEN PHARMACEUTICAL HOLD's weight in each manager's 13F, not the share of Biohaven Pharmaceutical Hold the manager owns.